Experts in oncology, healthcare, science, investment, and patient advocacy gathered for the Fortis Cancer Summit 2026 to discuss the future of cancer care [1].
The summit marks a shift toward multidisciplinary collaboration, aiming to move the field beyond traditional evidence-based treatment to improve patient outcomes.
Organized by Fortis Healthcare, the conference focused on the theme “Beyond Evidence, Based Oncology” [1]. The event brought together a diverse group of professionals to explore how technology and innovation can transform the way clinicians approach cancer treatment [1, 2].
Participants discussed the integration of patient-first innovations into standard practice. The goal is to create a healthcare environment where investment and scientific research align more closely with the immediate needs of patients [1, 2].
By focusing on a multidisciplinary approach, the summit highlighted the necessity of breaking down silos between different medical specialties. This collaboration is intended to accelerate the delivery of new treatments and improve the precision of oncology care [1].
The event took place in 2026 [1]. It served as a forum for identifying the gaps in current oncology frameworks and proposing new models for care delivery that prioritize the patient experience alongside clinical data [1, 2].
“The summit marks a shift toward multidisciplinary collaboration.”
The focus on 'beyond evidence-based' care suggests a transition toward precision medicine and personalized oncology. By integrating investment and patient advocacy into the scientific process, the medical community is attempting to shorten the gap between laboratory breakthroughs and bedside application.
